Production (Stage)
Protagenic Therapeutics, Inc.
PTIX
$3.62
$0.1353.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 873.00K | 1.84M | 1.06M | 924.60K | 2.42M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 55.20K | 44.40K | 366.90K | 444.30K | 44.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 928.20K | 1.88M | 1.42M | 1.37M | 2.47M |
|
|
|||||
| Total Current Assets | 928.20K | 1.88M | 1.42M | 1.37M | 2.47M |
| Net Property, Plant & Equipment | 60.50K | 73.00K | 85.60K | 98.20K | 110.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 988.70K | 1.96M | 1.51M | 1.47M | 2.58M |
|
|
|||||
| Total Accounts Payable | 165.20K | 103.00K | 108.60K | 93.50K | 109.00K |
| Total Accrued Expenses | 911.70K | 839.80K | 680.70K | 581.10K | 337.10K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.08M | 942.80K | 789.30K | 674.60K | 446.10K |
|
|
|||||
| Total Current Liabilities | 1.08M | 942.80K | 789.30K | 674.60K | 446.10K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.08M | 942.80K | 789.30K | 674.60K | 446.10K |
|
|
|||||
| Common Stock & APIC | 37.78M | 37.45M | 35.60M | 35.03M | 34.72M |
| Retained Earnings | -37.74M | -36.30M | -34.75M | -34.11M | -32.50M |
| Treasury Stock & Other | -129.90K | -129.90K | -130.20K | -130.20K | -86.80K |
| Total Common Equity | -88.30K | 1.01M | 719.00K | 792.50K | 2.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -88.30K | 1.01M | 719.00K | 792.50K | 2.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -88.30K | 1.01M | 719.00K | 792.50K | 2.13M |
|
|
|||||